A new migraine treatment awaits for FDA approval, what you need to know.

A new migraine treatment awaits for FDA approval, what you need to know.

The NJ star ledger has reported that a Bernards based company has a device that can potentially short circuit a migraine when it begins to occur. Migraines typically are genetic and typically have a trigger, such as certain foods, allergens, etc. They are caused by a vaso constriction in the brain (the blood vessels constrict) and then a vaso dilation (blood vessels open) which causes the headache and can incapacitate someone.

If you have a migraine that occurs from one of these common triggers, this can potentially be quite helpful in managing the pain and disability and a better option than medications which have side effects.

Another management option is chiropractic manipulation and chiropractic care. One of the most common reasons for migraines is asymmetry in the musculoskeletal system and tightness on one side as compared to the other. This device may help the episode, however the chiropractic approach gets at the cause. People with better functioning body mechanics report fewer migraines.

Check out the article on this device.

For migraine headaches, electrical current may provide lasting relief

Ed Murray/The Star-Ledger

The throbbing in your head can be so intense it feels like a tornado is trapped inside.

For the millions of people with migraine headaches, light and sound can become unbearable, with accompanying dizziness and nausea, making it difficult to walk without experiencing pain.

But instead of aspirin or prescription drugs — the current available remedies — a Somerset County-based medical device company says it has developed a more efficient way to find relief.

The company, electroCore of Bernards Township, has developed a handheld device that sends electrical impulses along the vagus nerve, actually two nerves that run through the neck to the brain. Each dose lasts about two minutes, administered by pressing the device to the neck.

In the trial studies submitted to the Food and Drug Administration, 70 percent of patients found meaningful relief within 15 to 30 minutes.

Dubbed gammaCore, the device, which resembles an electric razor, works by sending signals into the brain that reduce the amount of a substance called glutamate that has been associated with headache symptoms.

Headache specialists that include neurologists and psychiatrists say gammaCore has shown promise, with fewer side effects, quicker results and easier application than drug alternatives.

Brian Gerhardstein, a neurologist at Rutgers-Robert Wood Johnson Medical School in New Brunswick, said preliminary studies of gammaCore have been positive, though more data results is needed.

read more